BROWN BROTHERS HARRIMAN & CO - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
BROWN BROTHERS HARRIMAN & CO ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$21
-27.6%
80.0%0.00%
Q2 2023$29
+70.6%
80.0%0.00%
Q1 2023$17
-82.3%
80.0%0.00%
Q4 2022$9680.0%0.00%
Q3 2022$080.0%0.00%
Q2 2022$080.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 315,301$1,444,0001.50%
Private Portfolio Partners LLC 54,010$247,3660.07%
Knoll Capital Management, LLC 20,000$92,0000.05%
Urban Wealth Management, LLC 2,858$13,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 100,216$459,0000.04%
XTX Topco Ltd 18,174$83,0000.03%
Rossmore Private Capital 40,661$186,0000.03%
Ergoteles LLC 224,700$1,029,0000.03%
ETF MANAGERS GROUP, LLC 87,365$393,0000.01%
Belvedere Trading LLC 40,690$343,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders